CPOX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.739400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.294800E-01
Normal-vs-Stage2
5.923000E-01
Normal-vs-Stage3
6.243800E-01
Normal-vs-Stage4
6.291400E-01
Stage1-vs-Stage2
5.587400E-01
Stage1-vs-Stage3
1.580780E-01
Stage1-vs-Stage4
5.684200E-01
Stage2-vs-Stage3
1.558610E-01
Stage2-vs-Stage4
9.357000E-01
Stage3-vs-Stage4
4.136200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.320200E-01
Normal-vs-AfricanAmerican
5.528000E-01
Normal-vs-Asian
3.664000E-01
Caucasian-vs-AfricanAmerican
5.757600E-01
Caucasian-vs-Asian
2.198000E-01
AfricanAmerican-vs-Asian
7.852800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.243000E-01
Normal-vs-Female
6.111000E-01
Male-vs-Female
5.904400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.805400E-01
Normal-vs-Age(41-60Yrs)
3.354200E-01
Normal-vs-Age(61-80Yrs)
8.293200E-01
Normal-vs-Age(81-100Yrs)
7.421800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.859570E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.057000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.867800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.030300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.385200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.142800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.797600E-01
Normal-vs-Daily Drinker
7.267200E-01
Normal-vs-Weekly Drinker
6.535800E-01
Normal-vs-Occasional Drinker
4.864000E-01
Normal-vs-Social Drinker
5.772200E-01
Non Drinker-vs-Daily Drinker
7.430800E-01
Non Drinker-vs-Weekly Drinker
9.104000E-01
Non Drinker-vs-Occasional Drinker
4.110600E-01
Non Drinker-vs-Social Drinker
5.674400E-01
Daily Drinker-vs-Weekly Drinker
8.323600E-01
Daily Drinker-vs-Occasional Drinker
7.072200E-01
Daily Drinker-vs-Social Drinker
8.453400E-01
Weekly Drinker-vs-Occasional Drinker
5.012200E-01
Weekly Drinker-vs-Social Drinker
6.540000E-01
Occasional Drinker-vs-Social Drinker
8.622400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.189600E-01
Normal-vs-Grade 2
7.118600E-01
Normal-vs-Grade 3
7.152600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.437480E-03
Grade 1-vs-Grade 3
6.355600E-03
Grade 1-vs-Grade 4
9.189600E-01
Grade 2-vs-Grade 3
9.528200E-01
Grade 2-vs-Grade 4
7.118600E-01
Grade 3-vs-Grade 4
7.152600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.958000E-01
Normal-vs-NonDiabetic
6.397600E-01
Diabetic-vs-NonDiabetic
3.463000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.922200E-01
Normal-vs-NoPancreatitis
7.837400E-01
Pancreatitis-vs-NoPancreatitis
7.800400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.053800E-01
Normal-vs-N1
6.369800E-01
N0-vs-N1
8.480800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.132200E-01
Normal-vs-TP53-NonMutant
9.591200E-01
TP53-Mutant-vs-TP53-NonMutant
4.205900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
